TEV protease variant, fusion protein thereof, preparation method therefor and use thereof
AssigneeShangrao Concord Pharmaceutical Co., Ltd.
InventorsRikui Liu, Xiaolong Zou, Jianghua Wan
Life of this patent
Estimating the term…
Loading patent…
AssigneeShangrao Concord Pharmaceutical Co., Ltd.
InventorsRikui Liu, Xiaolong Zou, Jianghua Wan
Estimating the term…
Provided are a TEV protease variant, a fusion protein thereof, a preparation method therefor and the use thereof. Provided are a TEV protease variant with unique properties obtained by screening and a fusion protein thereof. The TEV protease variant has a low enzyme cleavage activity during expression in hosts, and preferably has a lower enzyme cleavage activity compared to an S219V variant having an amino acid sequence as shown in SEQ ID NO: 10. The enzyme cleavage site of the TEV protease variant is selected from EXXYXQG/S/H, wherein X is any amino acid residue, and the enzyme cleavage site is preferably selected from SEQ ID NO: 7 and 8. Fusion expression using the TEV protease variant of the present invention and a polypeptide can be used for preparing a polypeptide quickly and efficiently, thereby solving the problems currently present in the process of the recombinant production of a polypeptide.
A TEV protease variant, wherein the TEV protease variant comprises mutations selected from the group consisting of:
Dependencies are inferred from the claim text.